Brigitte Birebent

Introduction

Brigitte Birebent is a notable inventor based in Yebles, France. She has made significant contributions to the field of cell therapy, particularly through her innovative methods involving T effector cells. Her dedication and research have led to the development of a unique approach to sort T effector cells from human leukocytes.

Latest Patents

Brigitte holds one patent titled "Method effector cells using anti-CD127 antibodies for applications in cell therapy." This invention relates to methods and preparations for sorting T effector cells from human leukocytes using anti-CD127 antibodies. The method allows for the discriminative depletion of subpopulations of regulatory T cells that express CD127+ at low levels, enabling the recovery of selected cell preparations primarily composed of T effector cells. This innovative approach aims to improve therapeutic efficacy, especially when administered to patients.

Career Highlights

Throughout her career, Brigitte Birebent has worked with prominent organizations such as Ose Immunotherapeutics and Etablissement Francais Du Sang. Her contributions to these companies have been instrumental in advancing the research and application of cell therapies.

Collaborations

Brigitte has collaborated with esteemed colleagues, including Bernard Vanhove and Nicolas Poirier. These partnerships have fostered a rich environment for innovation, enhancing the potential applications of her work in the medical field.

Conclusion

Brigitte Birebent's contributions to cell therapy through her innovative patent demonstrate her commitment to advancing medical science. Her work, supported by collaborations with industry experts, continues to pave the way for effective therapies that may improve patient outcomes. As an inventor, she exemplifies the impact of creativity and research in the field of healthcare innovation.